Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights - Novartis ( NYSE:NVS )
On Tuesday, Novartis AG NVS reported third-quarter sales of $12.823 billion, up 9% ( +10% on constant currency ) , beating the consensus of $12.76 billion. Guidance: Novartis also raised its 2024 full-year guidance again this year.
| Ticker |
Sentiment |
Impact |
|
KYMR
|
Somewhat Bullish
|
15 %
|
|
LLY
|
Neutral
|
15 %
|
|
INCY
|
Somewhat Bullish
|
15 %
|
|
NVS
|
Neutral
|
22 %
|
|
ABBV
|
Somewhat Bullish
|
15 %
|
|
GS
|
Neutral
|
7 %
|
|
REGN
|
Neutral
|
15 %
|
|
YMAB
|
Neutral
|
15 %
|
|
AMGN
|
Neutral
|
15 %
|
|
BIIB
|
Somewhat Bullish
|
15 %
|
|
BMY
|
Neutral
|
15 %
|
